[1]
“In-silico Investigation of SCN2A-Associated Epilepsy and Ligand Binding Affinity of NAG”, Int. j. appl. clin. res., vol. 4, no. 03, pp. 25–31, Sep. 2026, doi: 10.66222/IJACR.04.03.61.